VIZAMYL

This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Japan, Lithuania, Poland, Singapore, Turkey, United States

Active ingredients

The drug VIZAMYL contains one active pharmaceutical ingredient (API):

1 Flutemetamol ¹⁸F
UNII L49M066S0O - FLUTEMETAMOL F-18

Flutemetamol ¹⁸F binds to β-amyloid neuritic plaques in the brain. It is a radiopharmaceutical medicinal product indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment. VIZAMYL should be used in conjunction with a clinical evaluation.

Read about Flutemetamol ¹⁸F

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VIZAMYL Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V09AX04 V Various → V09 Diagnostic radiopharmaceuticals → V09A Central nervous system → V09AX Other central nervous system diagnostic radiopharmaceuticals
Discover more medicines within V09AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1662588, 1662599
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 114941002
Country: FR Base de données publique des médicaments Identifier(s): 67652999
Country: IT Agenzia del Farmaco Identifier(s): 043562014, 043562026
Country: JP 医薬品医療機器総合機構 Identifier(s): 43004A4A1028
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1073834, 1073835
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100326514
Country: SG Health Sciences Authority Identifier(s): 15441P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699360730355
Country: US FDA, National Drug Code Identifier(s): 17156-067

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.